Integrated Pulmonary Index as a Predictor of Respiratory Compromise in Critically Ill Patients
1 other identifier
observational
70
0 countries
N/A
Brief Summary
The integrated pulmonary index (IPI) is a newly developed index for respiratory monitoring. However, there is limited evidence on its effectiveness and usefulness in critically ill patients. The purpose of this study is to evaluate the clinical relevance of the IPI as a predictor of respiratory compromise in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2024
CompletedFirst Posted
Study publicly available on registry
May 2, 2024
CompletedStudy Start
First participant enrolled
May 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2024
CompletedMay 2, 2024
April 1, 2024
6 months
April 23, 2024
April 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Respiratory Failure
1. Hypoxia 2. Hypercapnia
6 months
Secondary Outcomes (1)
Complications
6 months
Study Arms (2)
Respiratory compromise (RC) group
Non respiratory compromise (RC) group
Interventions
After admission to the ICU, patients will be continuously monitored with ICU standard monitoring in addition to IPI using (Capnostream™ Medtronic). IPI will be recorded after transfer to the ICU, as well as at 2, 6, 12, 18 and 24 hours.
Eligibility Criteria
Included patients will receive the standard care, according to the usual standard clinical practice at the institution. After admission to the ICU, patients will be continuously monitored with ICU standard monitoring in addition to IPI using (Capnostream™ Medtronic). IPI will be recorded after transfer to the ICU, as well as at 2, 6, 12, 18 and 24 hours. Any respiratory, hemodynamic events or interventions will be recorded by the ICU nurses who will be blinded for the study.Demographic ( age, gender, BMI, co morbidities), clinical, laboratory, and outcomes data will be obtained from the medical records. Routine laboratory tests were done for all patients, including CBC, C-reactive protein, renal profile, coagulation profile and liver profile.
You may qualify if:
- Critically ill patients aged 18 years or older of both genders admitted to the intensive care unit
You may not qualify if:
- Age \< 18 years' old
- Morbid obesity
- Mechanical ventilation
- Hemodynamic instability.
- Thoracotomy and cardiac surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 23, 2024
First Posted
May 2, 2024
Study Start
May 15, 2024
Primary Completion
November 16, 2024
Study Completion
December 22, 2024
Last Updated
May 2, 2024
Record last verified: 2024-04